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Abstract 
Purpose: To synthesize a series of mixed ligand-metal complexes and to evaluate their alkaline 
phosphatase inhibitory capacities, antioxidant potential and antimicrobial activities. 
Method: Mixed ligand-metal complexes of Zn (II), Ni (II), Co (II), Cu (II), omeprazole and 8-
hydroxyquinoline were synthesized. The ligand-metal complexes were characterized by various 
physicochemical techniques, including elemental analysis, magnetic susceptibility, scanning electron 
microscope (SEM), mass spectrometry (EI-MS), ultraviolet-visible (UV-Vis) spectrophotometry, Fourier 
transform infrared spectroscopy (FTIR), proton nuclear magnetic resonance (1H-NMR) and conductance 
studies.  The new compounds were also investigated for their alkaline phosphatase (ALPs) inhibition, 
2,2’-diphenyl-1-picrylhydrazyl (DPPH) radical-scavenging and antimicrobial activities. 
Results: Spectroscopic studies revealed the chemical composition of synthesized compounds as well 
as the bidentate bonding behavior of the coordinating ligands with metal ions. Conductance 
measurement suggested that the metal complexes were non-electrolytes. Ni(II) complex exhibited 
antioxidant activity (30.48 ± 0.32 ߤM) higher than those of BHT (standard) and other complexes. 
Stronger inhibition of ALPs by Ni (II) mixed ligand complex compared to the other complexes was 
evident. The synthesized compounds showed moderate to very good antimicrobial activity against 
bacterial strains, i.e., Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Actinomyces 
viscosus, Staphylococcus aureus, Bacillus subtilis; as well as against the fungal strains, Candida 
albicans, Aspergillus flavus and Aspergillus niger. 
Conclusion: All the mixed ligand complexes demonstrate higher antioxidant, ALPs-inhibitory and 
antimicrobial activities than their corresponding ligands. This indicates their therapeutic potential as 
future drug candidates for the concerned diseases. 
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Omeprazole belongs to a class of substituted 
benzimidazole and has some clinical applications 
in treatment of peptic-acid diseases like gastric 
and esophageal ulceration and prevention of 
their relapse [1]. Acid inhibition strategies such 
as histamine H2-receptor antagonist and use of 
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anti-cholinergic agents have been employed to 
treat peptic ulcer disease. Omeprazole is a 
proton pump inhibitor which promotes reduction 
of parietal cells by a series of prototropic 
reactions. The long duration of action of parietal 
cell H+-K+-ATPase is due to prolonged binding of 
the active form of the drug [2-4]. Omeprazole has 
a privileged structure in pharmacophore and 
medicine chemistry. The importance of this 
compound is due to its bicyclic structure which is 
a fusion of benzene and imidazole rings. The 
plasma elimination half-life (t1/2β) of omeprazole 
is usually shorter than one hour, although a few 
individuals exhibit slower elimination (t1/2β ≈ 2h). 
These individuals have recently been shown to 
be poor hydroxylators of S-mephenytoin, which 
suggests that a major part of omeprazole 
metabolism is mediated by S-mephenytoin 
hydroxylase, an enzyme within the cytochrome 
P450 system [5,6].  
 
Omeprazole is completely metabolized and its 
average plasma clearance is 30 L/h. The drug 
also shows good antimicrobial activity against 
Helicobacter pylori [7-9]. 8-hydroxyquinoline is 
well-known for its antimicrobial activity. It has 
been comprehensively used for analytical 
determination of metal ions [10]. Cheatum et al 
[11] studied the dynamic excited state of HQL 
dimmers.  
 
In the present study, an attempt has been made 
to synthesize Zn (II), Co(II), Ni(II) and Cu(II) 
mixed ligand complexes of omeprazole and 8-
hydroxyquinoline. All the complexes were 
characterized by spectroscopic techniques and 




All chemicals and solvents of analytical grade 
were purchased from Merck and Sigma-Aldrich. 
UV-visible spectra were recorded from 200 - 800 
nm on Jasco UV visible spectrophotometer 
model V-770 UV-VIS. FT-IR spectra were 
recorded on Nicolet IS50, FT-IR 
spectrophotometer from 400-4000 cm-1. 
Elemental analyses were performed on a 
CHNS/O-2400 Series II elemental analyzer. 
Magnetic susceptibility was determined using 
Holmarc’s Magnetic Susceptibility (model HO-
ED-EM-07). Mass spectral measurement was 
performed on Finnigan MAT LCQTM mass 
spectrometer. The molar conductance of the 
synthesized complexes in DMSO was measured 
using a Conductivity Meter, Model WD-35604-00 
at 25 °C temperature. SEM images were 
recorded in a Hitachi SEM analyzer. 1H-NMR 
spectra were recorded in DMSO-d6 at room 
temperature using TMS as internal standard on a 
Bruker 400 MHz spectrophotometer. 
 
Synthesis of mixed ligand metal complexes  
Mixed ligand complexes were synthesized by 
mixing water-ethanol solutions (1:1, v/v) of metal 
salts (1 mmol), ethanolic solution of primary 
ligand (L) omeprazole (0.345 g, 1mmol) and 
secondary ligands 8-hydroxyquinoline (L2, 0.145 
g, 1 mmol) in molar ratio of 1:1:1 (M:L:L2).The 
resultant mixture was refluxed for 3-4 h and 
colored precipitates were obtained in each case. 
The solids precipitated were filtered and washed 
with diethyl ether-ethanol (1:1 v/v). Stability 
constants were also calculated. Figure 1 shows 
the structural formula of the mixed ligand metal 
complexes. 
 
Assay of inhibitory effects of metal 
complexes on ALPs  
 
The assay of inhibition of ALPs was done 
spectrophotometrically as described earlier [12]. 
Working substrate was prepared by mixing four 
parts of diethanolamine (pH = 9.8, 2 mol/dm3) 
and MgCl2 (0.5 mmol/dm3), and one part of p-
NPP (50 mmol/dm3). This substrate was 
incubated at 37oC for 5 min. The ALP assay of 
OMZ, HQL and metals complexes were 
determined by addition of 2 mL of working 
substrate to 40 µL of human serum. 
 
Figure 1: Reaction mechanism of mixed ligand metal complexes. (M = Zn(II), Ni(II), Co(II) and Cu(II)) 
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ALP activity was assayed with 25 mM stock 
solutions of OMZ, HQL and the synthesized 
complexes. After the incubation period, 
absorbance was recorded at 405 nm [13]. All 
measurements were done in triplicate and the 
mean of these values was used to calculate the 
percentage inhibition of ALPs activity. The 
principle of this assay is that colorless p-
Nitrophenyl phosphate (substrate) in alkaline 
medium changes to a yellow-colored due to 
liberation of p-Nitrophenol by ALPs. 
 
Determination of DPPH radical scavenging 
activity 
 
DPPH free radical scavenging activity is a rapid 
technique for assay of antioxidant activities of 
compounds. Using the method as described by 
Khan et al [14] the DPPH free radical scavenging 
potential of the mixed ligand complexes were 
determined relative to standard i.e. butylated 
hydroxytoluene (BHT). In the assays, OMZ, HQL 
and synthesized mixed ligand metals complexes 
at various concentrations (500, 250, 125 and 60 
μg/mL) were incubated with 3 ml of 0.1 mM 
DPPH in methanol for 60 min at room 
temperature. Absorbance was measured at 517 
nm against methanol. The absorbance was 
decreased by conversion of DPPH to the more 
stable DPPH2 molecules, which serves as an 
indication of the capacity of antioxidant 
compounds to donate hydrogen ion [15]. All 
measurements were taken in triplicates. DPPH 
radical scavenging activity was calculated using 
the formula: 
 
DPPH scavenging (%) = {(Ac - As)/Ac}100… (1) 
 
where Ac is the absorbance of control and As is 




The antimicrobial properties of OMZ, HQL and 
synthesized complexes were determined using 
the agar-well diffusion method [16]. Six bacterial 
strains including three Gram-negative strains, 
Klebsiella pneumoniae, Pseudomonas 
aeruginosa, Escherichia coli, and three Gram-
positive strains, Actinomyces viscosus, 
Staphylococcus aureus, and Bacillus subtilis 
were used.  Antifungal activity was determined 
against Candida albicans, Aspergillus nigar and 
Aspergillus flavus. The culture media was 
prepared by dissolving 28 g of nutrient agar in 1L 
of distilled water (for bacterial strains), and 38 g 
of potato dextrose agar in 1L of distilled water for 
fungi. The media were autoclaved at 121°C and 
15 LD/sq inch for 15 min. The stock solution (100 
μL in each dish) was put into Petri dishes and 
then allowed to attain room temperature. The 
microorganisms were cultured and incubated for 
24 h at 37 °C (for bacterial cultures) and for 48 h 
at 28 °C (for fungal cultures) [17,18]. Zones of 
inhibition in specimen Petri dishes were 
measured in mm with venire caliper in mm. The 
anti-fungal drug fluconazole and antibacterial 
drug ampicillin (100 μg/mL) were used as 
standard controls for comparison with the tested 
specimens under similar conditions. These 
assays were performed in triplicate, and the 




Analysis of data was carried out using Microsoft 
Excel-2016 software. All computations were 
executed in triplicate and the results were 
expressed as mean ± SEM (n = 3). Antimicrobial, 
DPPH and ALP assays were computed with 
suitable dilutions for each sample and different 
statistical techniques such as Duncan multiple 
range method, one-way analysis of variance 
were used for analysis of data obtained from 
different samples. P < 0.05 was taken as 




The synthesized mixture of ligand complexes 
showed yields that ranged from good to excellent 
yield (up to 89 %). The purity of the complexes 
was checked by melting point determination. 
Sharp melting points were obtained with fairly 
pure complexes. Low values of conductance 
measurements suggested the non-electrolyte 
nature of synthesized mixed ligand metal 
complexes. The chemical structures of all the 
synthesized compounds were deduced with the 
aid of physical and spectroscopic methods. 
Physical data and elemental (CHNS/O) analysis 
of these complexes were in good agreement with 
the proposed formulae. The general reaction 
equation (2) for the synthesis of the complexes is 
shown in Eq 2. 
 
OMZ + HQL + MCl2.nH2O                    
M(LL2).nH2O + 2HCl + H2 ......................... (2)   
 
where M = Zn(II) (n=0); M = Ni(II), Co(II) and 
Cu(II) (n = 2) 
 
Zn (II) Complex                      
 
Yield: 89 %; colour: White solid; m.p: 266-268 
°C; Molar conductance, Λm (in 10-3 M DMSO): 
5.6 ohm-1cm2mol-1; μeff: 1.71; Stability constant: 
11.647 log K (L/mole); Selected IR (KBr, cm-1): 
(S=O): 1023; (C=N)bnz: 1555; (C=N)HQL: 1632; 
(CO): 1723; (M-O): 479; (M-N): 435. Electronic 
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spectra (ߣmax in nm):289, 229. 1H NMR (400 
MHz, δ, DMSO-d6): 11.23 (s, 1H); 8.02, 8.41 (s, 
2H); 7.00-7.34 (m, 7H); 6.97 (d, 1H); 4.69 (s, 2H, 
CH2-pyridine); 3.51 (s, 6 H); 2.16 (d, 6H). Anal. 
Calc. for C26H25N4O4SZn (MW: 554.95 g/mol): C, 
56.27; H, 4.54; N, 10.10; S, 5.78; O, 11.53; Zn, 
11.78% and Found: C, 56.36; H, 4.91; N, 10.19; 
S, 5.61; O, 11.59; Zn, 11.68%; MS (m/z, (relative 
abundance, %)): 554 [M+, 9.5]. 
 
Co (II) Complex 
 
Yield: 77 %; colour: Light green; m.p: 249-251 
°C; Molar conductance, Λm (in 10-3 M DMSO):   
5.9 ohm-1cm2mol-1; μeff: 3.21; Stability constant: 
11.421 log K (L/mole); Selected IR (KBr, v, cm-1): 
(S=O): 1027; (C=N) bnz: 1549; (C=N)8HQ: 1635; 
(CO): 1731; (H2O): 3600-2700; (M-O): 486; (M-
N): 439. Electronic spectra (ߣmax in nm): 290, 
226. 1H NMR (400 MHz, δ, DMSO-d6): 12.09 (s, 
1H); 8.03, 8.36 (s, 2H); 7.03-7.43 (m, 7H); 6.81 
(d, 1H); 4.63 (s, 2H, CH2-pyridine); 3.53 (s, 4H; 
2H2O); 2.11 (d, 6H). Anal. Calc. for 
C26H29N4O6SCo (MW: 584.529 g/mol): C, 53.42; 
H, 5.00; N, 9.58; S, 5.49; O, 16.42; Co, 10.08% 
and found: C, 53.56; H, 4.91; N, 9.42; S, 5.69; O, 
16.61; Co, 9.89%. MS (m/z, (relative abundance, 
%)):584 [M+, 14.9].  
 
Ni (II) Complex 
 
Yield: 83 %; colour: Light Brown; m.p, 241-244 
°C; Molar conductance, Λm (in 10-3 M DMSO):  
5.7 ohm-1cm2mol-1; μeff: 3.42; Stability constant: 
10.567 logK(L/mole); Selected IR (KBr, v, cm-1): 
(S=O): 1032; (C=N)bnz: 1534; (C=N)8HQ: 1637; 
(CO): 1733; (H2O): 3600-2700; (M-O): 488; (M-
N): 443. Electronic spectra (ߣmax in nm): 294, 
223. 1H NMR (400 MHz, δ, DMSO-d6): 11.23 (s, 
1H); 8.03, 8.41 (s, 2H); 7.02-7.31 (m, 7H); 6.99 
(d, 1H); 4.64 (s, 2H, CH2-pyridine); 3.53 (s, 6 H); 
3.48 (s, 4H, 2H2O); 2.16 (d, 6H). Anal. Calc. for 
C26H29N4O6SNi (MW: 584.29 g/mol): C, 53.45; H, 
5.00; N, 9.59; S, 5.49; O, 16.43; Ni, 10.05% and 
Found: C, 53.78; H, 4.93; N, 9.64; S, 5.44; O, 
16.49; Ni, 10.16%. MS (m/z, (relative abundance, 
%)):584 [M+, 12.3]. 
 
Cu (II) Complex 
 
Yield: 88 %; colour: Yellowish white: m.p., 223-
227 °C; Molar conductance, Λm (in 10-3 M 
DMSO): 5.6 ohm-1cm2mol-1; Magnetic 
susceptibility, μeff: 3.79; Stability constant: 11.289 
logK (L/mole); Selected IR (KBr, v, cm-1): (S=O): 
1028; (C=N)bnz: 1559; (C=N)8HQ: 1623; (CO): 
1727; v(H2O): 3600-2700; v(M-O): 483; v(M-N): 
449. 1H NMR (400 MHz, δ, DMSO-d6): 11.23 (s, 
1H); 8.05, 8.44 (s, 2H); 7.02-7.71 (m, 7H); 6.91 
(d, 1H); 4.68 (s, 2H, CH2-pyridine); 3.59 (s, 6 H); 
3.42 (s, 4H, 2H2O); 2.16 (d, 6H). Electronic 
spectra (ߣmax in nm): 343, 227 Anal. Calc. for 
C26H29N4O6SCu (MW: 589.14 g/mol): C, 53.01; 
H, 4.96; N, 9.51; S, 5.44; O, 16.29; Cu, 10.79% 
and found: C, 53.28; H, 5.02; N, 9.49; S, 5.52; O, 
16.19; Cu, 11.01%.MS (m/z, (relative 




The mixed ligand metal complexes had magnetic 
moments in the range of 1.71-3.79 B.M. Zn(II) 
complexes usually have distorted square planer 
configuration and a magnetic moment was 1.71 
B.M. The Ni(II), Co(II) and Cu(II) complexes also 
support their octahedral geometry with magnetic 
moments of 3.42, 3.21 and 3.79 B.M, 
respectively. 
 
FT-IR studies  
 
The two main regions are of interest in mixed 
ligand complexes because they give valuable 
information about the coordination behavior of 
ligands to metals. These are C=N and S=O 
(sulphonic acid group). In the IR spectra of OMZ, 
a peak appeared at 3560 cm-1.  This peak was 
due to the stretching vibration of v(N-H) in 
benzimidazole. The stretching vibration of C=N 
occurs at 1586 cm-1 while that of S=O occurs at 
1010 cm-1. In the case of 8-hydroxyquinoline 
(HQL) molecules, the stretching vibration of 
v(CO) appears in medium peak at 1712 cm-1 
whereas v(C=N) and v(OH) stretching vibrations 
occur at 1643 cm-1 and 3453 cm-1, respectively.  
 
In the FTIR spectra of the mixed ligand metal 
complexes, the stretching vibration of v(N-H) of 
the benzimidazole appeared at ~3060 cm-1, 
indicating its non-involvement in coordination 
with metal ions. The peaks for v(S=O) (sulphonic 
acid group) appeared between 1023 and 1032 
cm-1, with a shift of 13-22 cm-1 to the higher wave 
number relative to OMZ, indicating the 
involvement of S=O group in the coordination of 
the complexes. The region between 1559-1534 
cm-1 was allocated to the v(C=N)bnz vibrations of 
all the complexes with shift of 27-52 cm-1 to the 
lower wave number, than C=N bond become 
weak due to dπ-pπ (metal to ligand) back 
donation and it shifts to lower wave number 
which indicating its involvement in coordination 
with metal ions. In the case of stretching 
vibrations, v(C=N)HQL appeared at 1623-1637 
cm-1 but it also shift to lower wave number of 6-
20 cm-1. 
  
The stretching vibration of v(CO) (HQL) 
appeared between 1723-1733 cm-1, with shift of 
11-21 cm-1 to the higher wave number, 
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confirming attachment to metal ions. The shifting 
of peaks of the C=N, S=O and CO on 
complexation gives valuable information about 
the point of attachment of metal ions to OMZ and 
8- HQL; this also confirms that OMZ and HQL 
behave as bidentate ligands. In the case of HQL 
there is a considerable shift in the frequencies of 
O and C=N group and also acting as a bidentate 
ligand due to coordination with metal in all the 
complexes. The broad-stretching vibration bands 
found within the range 3600-2700 cm-1 was 
assigned to the coordination of water molecules 
in the Cu(II) and Ni(II) complexes. New 
absorption bonds of M-O stretching mode of 
vibration were assigned 479-488 cm-1 of the 
synthesized complexes, while M-N stretching 
vibration mode was assigned within the range of 
435-449 cm-1. 
 
Electronic absorption spectra 
 
The absorption spectra of 2.5 x 10-3M solutions 
of OMZ, HQL and synthesized complexes in 
DMSO were recorded from 200 to 800 nm at 
room temperature. UV spectra showed high 
absorption intensity in ultraviolet (UV) region due 
to presence of benzimidazole chromosphere and 
these complexes are inactive in the visible 
region. Two strong bands were observed for 
OMZ at 257 and 300 nm, and for 8-
hydroxyquinoline at 263 and 293 nm. These 
bands were attributed to n→π* and π→π* 
electronic transition in the framework of the 
synthesized complexes. In all the complexes, 
bands that commonly appeared in- between 289-
343 nm were attributed to intra ligand transitions 
consistent with electronic transition of C=N 
group. Upon complexation, the absorption bands 
of the complexes were slightly shifted to higher 
wavelength (red shift) compared to those of the 
free ligand omeprazole as well as 8-
hydroxyquinoline. These modifications of the 
shifts and intensities of the absorption bands 
indicate the coordination of the ligand to the 
metal ions. A square-planar arrangement around 
Zn (II) complex is supported due to occurrence of 
intermolecular charge transfer and ligand-to-
metal charge transfer (LMCT) at 289 and 229 
nm, respectively. However in Co (II), Ni (II) and 
Cu (II) complexes, the structural geometry is 
octahedral due to attachment of water molecule. 
This was confirmed by FT-IR spectra of these 
complexes. 
 
Morphological and structural properties of 
synthesized metal ligand complexes 
 
The morphological and structural properties of 
the mixed ligand metal complexes were 
evaluated using scanning electron microscopy 
(SEM). The SEM micrographs are shown in 
Figure 2. Zn (II) and Co (II) complexes showed 
particles with sizes in the nanometer range, and 
their structures are homogenous. Some Ni (II) 
and Cu (II) complexes were irregularly-shaped 
and well-separated from each other, while most 
are present in agglomerated forms. Thus, these 
SEM results confirmed the nano-structured 





Figure 2: SEM images of mixed ligand metal complexes. (A) = Zn(II); (B) = Co(II); (C) = Cu(II) and (D) 
= Ni(II) 
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1H NMR Spectra 
 
The 1H NMR spectra of the synthesized mixed 
ligand complexes was obtained in deuterated 
DMSO-d6. In 1H NMR spectrum, the signal that 
appeared around the δ 3.42-3.51 ppm was 
assigned to O-CH3, while methylene (-CH2) 
protons were responsible for the doublet peak at 
δ 4.64-4.69 ppm in all the synthesized 
complexes. The NMR signals for CH group were 
observed downfield in comparison to normal 
position because of the electron-withdrawing 
effect of neighboring atoms like nitrogen and 
oxygen in five-membered rings which make it 
more de-shielded.  
 
There was a weak signal at 2.16 ppm which may 
be assigned to the methyl (-CH3) protons but its 
integration showed otherwise. It may be that it 
was unusually merged with the DMSO peak. Due 
to non-involvement of NH proton in coordination, 
the singlet peak was observed at 11.23 ppm in 
all the synthesized complexes. The aromatic 
hydrogens were observed at δ 6.916-8.446 ppm. 
Figure 3 shows the 1H NMR spectra of Zn (II) 
mixed ligand complex. 
 
Mass spectra  
 
The mass spectra were recorded for synthesized 
mixed ligand complexes at 300 °C and 70 eV. All 
the spectra exhibited parent peaks due to 
molecular ions. The proposed molecular 
formulae of these complexes were confirmed by 
comparing their molecular formula weights with 
m/z values. Molecular ion peaks were observed 
in complexes of Zn (II), Ni (II), Cu (II) and Co (II) 
at m/z 554, m/z 584, m/z 589, m/z 584, 
respectively. This was in line with the 
composition of synthesized complexes. Mass 
spectra of Zn (II) and Ni (II) complexes are 
shown in Figure 4 and Figure 5. 
 
 
Figure 3: 1H NMR spectra of Zn (II) mixed ligand complex 
 
 
Figure 4: Mass spectra of Zn (II) mixed ligand Complex 
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   Figure 5: Mass spectra of Ni (II) mixed ligand complexes 
 
Inhibitory effects on ALPs activity  
 
OMZ, HQL and the mixed ligand complexes were 
examined for their inhibition against ALPs. All the 
synthesized complexes exhibited concentration–
dependent inhibitory activities against ALPs. The 
exact mechanism involved in this inhibition is not 
clear. ALPs assay was carried out at different 
specimen concentrations (0.24, 0.48, 0.73 and 
0.96 mM). Graphical representation of the effects 
of OMZ, HQL and synthesized complexes on 
ALPs is shown on Figure 6. It was also found 
that at a concentration of 0.96 mM, ALPs 
inhibition ranged from 80 to 98 % for all the 
complexes. Among the bimetallic complexes, the 
highest ALPs inhibition was observed with Ni (II) 
complex, followed by OMZ, HQL and other 
complexes. The order of inhibition of ALPs by the 
synthesized compounds was Zn (II) > Ni(II) > 
Co(II) > Cu(II) > OMZ > HQL. 
 
DPPH radical scavenging activity 
 
DPPH is a stable organic compound and it is 
extensively used for oxidative assay of the 
proton-donation ability of the samples. The 
results of free radical scavenging ability of the 
tested compounds are shown in Figure 7. All the 
complexes showed good antioxidant activity with 
respect to DPPH scavenging potential. Ni (II) 
complex (IC50 = 30.48±0.30) showed higher 
DPPH scavenging activity than Zn (II), Co (II) 
and Cu (II) complexes. Ni (II) complex was also 
better than BHT (IC50 = 40.31±0.4166 μM). The 
Cu (II) mixed ligand complex (IC50 = 36.11±0.37) 
was active but had lower DPPH radical–
scavenging activity than other synthesized 
complexes and BHT. The order of DPPH 
scavenging was Ni (II) > Co(II) > Zn(II) > Cu(II) > 
OMZ > BHT > HQL. 
 
         Figure 6: Inhibition of ALPs by OMZ, HQL and synthesized complexes 
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Figure 7: IC50 values in DPPH radical scavenging activities of ligands and synthesized complexes 
 
Antibacterial activities of synthesized metal 
ligand complexes  
 
The antibacterial activity of OMZ, HQL and 
synthesized complexes were investigated 
against three gram-negative strains, E. coli, P. 
aeruginosa, and K. pneumoniae, as well as three 
gram-positive strains, A. viscosus, S. aureus and 
B. subtilis. Cu(II) complex had the largest zones 
of inhibition against E. coli, S. aureus and A. 
viscosus. Ni(II) complex produced the largest 
antibacterial activity against P. aeruginosa and E. 
coli. Zn (II) complex higher inhibition zones for K. 
pneumoiae than any of the other complexes or 
Ampicillin. The order of antibacterial activity of 
the compounds was Cu(II) > Ni(II) > OMZ > 
Zn(II) > HQL > Ampicillin. The antibacterial 
effects of OMZ, HQL and synthesized complexes 
against both gram-negative and gram-positive 
microscopic organisms are shown in Table 1. 
 
Antifungal activity of synthesized complexes 
 
The antifungal activities of OMZ, HQL and 
synthesized complexes were determined against 
three parasitic strains: C. albicans, A. flavus, and 
A. niger. The complexes showed highest 
antifungal activity against fungal strains due to 
presence of S=O and C=N groups in their 
structures. Zn (II) complex showed the highest 
zones of inhibition against C. albicans and A. 
niger, while Co (II) complex had the highest 
activity against C. albicans and A. flavus. Cu (II) 
complex was more active against A. niger but 
lower in activity than OMZ. The order of 
antifungal activity of the compounds was Zn(II) 
>Co(II) >Ni(II) >Cu(II) >OMZ > HQL > 
Fluconazole. The antifungal activity of OMZ, HQL 





In the present study, new and mixed ligand metal 
complexes were synthesized, and characterized 
by elemental analysis, conductance 
measurements, UV-visible, Mass spectra, SEM, 
IR and 1H-NMR.The major absorption bands in 
FTIR spectrum appeared at υmaxcm-11023-1032 
(S=O, str.), 1559-1534 (C=N, str.)bnz and 1623-
1637 for (C=N, str.)HQL. Stretching vibration of  
 





Zone of Inhibition (mm) 













OMZ 23±0.21 21±0.03* 19±0.34 19±0.36 21±0.23 23±0.26 
HQL 18±0.14 19±0.46 16±0.61 16±0.41* 14±0.72* 17±0.63 
Zn (II) 21±0.25* 19±0.23* 18±0.46 17±0.37 19±0.31 21±0.27 
Co (II) 19± 0.37 24±0.32* 17±0.61 24±0.21* 19±0.34 23±0.23 
Ni (II) 19±0.32 20±0.33* 19±0.56 29±0.14 24±0.20 28±0.09* 
Cu (II) 21±0.25* 30±0.11 29±0.34* 27±0.16 25±0.23 28±0.06* 
*Ampicillin 14±0.43 16±0.37 15±0.46 14±0.52 13±0.73 15±0.41 
*P˂0.05,1Standard drug; the diameter of inhibition zones are means of triplicate determinations± SEM and p < 
0.05 were compared with negative control 
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Table 2: Zones of inhibition of OMZ, HQL and synthesized mixed ligand complexes (100 µg/mL) against the 
fungal strains 
 
Compounds Zone of inhibition (mm) 
 Aspergillus nigar Aspergillus flavus Candida albicans 
OMZ 18±0.33 17±0.52 21±0.24 
HQL 14±0.54 16±0.63 13±0.52 
Zn (II) 21±0.25 25±0.13 27±0.13 
Co (II) 21±0.23 19±0.41 16±0.53 
Ni (II) 24±0.13 23±0.24 18±0.36 
Cu (II) 13±0.72 16±0.54 19±0.33 
1FLuconazole 12±0.68 14±0.50 11±0.61 
1standard drug; the diameter of inhibition zones are means of triplicate determinations ± SEM.  
 
v(CO)HQL appeared at 1723-1733 cm-1. This 
confirms coordination behavior with metal ions 
[19-22]. FTIR spectroscopy showed that OMZ 
and HQL acted as neutral bidentate ligands. The 
λmax of OMZ was observed at 257 and 300 nm, 
and at 263 and 293 nm for 8-hydroxyquinoline. 
These absorption peaks are due to n→π* 
andπ→π* electronic transition [23]. The 
electronic spectra of the synthesized mixed 
ligand complexes were in the range of 300-350 
nm. The presence of aliphatic and aromatic 
protons in the mixed ligand complexes was 
observed within the expected areas of the proton 
NMR spectra. The proposed structures of these 
complexes were confirmed by comparing their 
molecular formula weights with m/z values. The 
magnetic moment of all the synthesized 
complexes were observed in the range of 1.71-
3.79 B.M. Spectroscopic studies used to verify 
the chemical composition of products (as well as 
geometry of the complexes and molar 
conductance) indicated that the synthesized 
metal complexes were non-electrolytes in nature. 
The complexes, at 0.96 mM exhibited 80-98 % 
inhibition of ALPs [17].  Zn(II) complex was more 
active against the enzyme than OMZ, HQL and 
other complexes. All the complexes showed 
higher antioxidant activity when compared to 
OMZ, HQL and BHT. The DPPH radical 
scavenging activity of Ni(II) complex (IC50 = 
30.48±0.3031) was highest when compared with 
those of Ni(II), Co(II) and Cu(II) complexes, as 
well as BHT (IC50 = 40.31±0.42 μM) [24]. Cu (II) 
complex had the highest antibacterial activity 
against the bacterial strains, while Zn(II) complex 





A new series of mixed ligand complexes have 
been successfully synthesized and characterized 
by spectroscopic techniques. All the synthesized 
metal complexes possessed good antioxidant 
and antimicrobial properties. All the mixed ligand 
complexes demonstrated higher antioxidant, 
ALPs-inhibitory and antimicrobial activities than 
their corresponding ligands. This indicates their 
enormous therapeutic potential as future drug 
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